Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: Results from the BACH (Biomarkers in Acute Heart Failure) trial

European Journal of Heart Failure

Volumn 14, Issue 3, 2012, Pages 278-286

  Maisel, Alan ^a,b   Neath, Sean Xavier ^b   Landsberg, Judd ^a,b   Mueller, Christian ^c   Nowak, Richard M ^d   Peacock, W Frank ^e   Ponikowski, Piotr ^f   Möckel, Martin ^g   Hogan, Christopher ^h   Wu, Alan H B ⁱ   Richards, Mark ^j   Clopton, Paul ^a   Filippatos, Gerasimos S ^k   Di Somma, Salvatore ^l   Anand, Inder ^m   Ng, Leong L ⁿ   Daniels, Lori B ⁱ   Christenson, Robert H ^o   Potocki, Mihael ^c   McCord, James ^d   Terracciano, Garret ^b   Hartmann, Oliver ^p   Bergmann, Andreas ^q   Morgenthaler, Nils G ^g   Anker, Stefan D ^g,r   more..

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d HENRY FORD HEALTH SYSTEM   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f WROCLAW MEDICAL UNIVERSITY   (Poland)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^h VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j UNIVERSITY OF OTAGO   (New Zealand)

^k NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^l SAPIENZA UNIVERSITY OF ROME   (Italy)

^m VA Minneapolis ^*  (United States)

ⁿ UNIVERSITY OF LEICESTER   (United Kingdom)

^o UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^p Biotechnology Centre Hennigsdorf   (Germany)

^q Waltraut Bergmann Foundation   (Germany)

^r IRCCS SAN RAFFAELE PISANA   (Italy)

more..

Author keywords

Acute heart failure; Diagnosis; Pneumonia; Procalcitonin; Survival

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CLOPIDOGREL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROCALCITONIN; STEROID; WARFARIN;

ACUTE HEART FAILURE; ADULT; AGED; ANTIBIOTIC THERAPY; AREA UNDER THE CURVE; ARTICLE; ASTHMA; BACTERIAL INFECTION; BLOOD SAMPLING; BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DYSPNEA; EMERGENCY WARD; FEMALE; HEART ARRHYTHMIA; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; NEBULIZER; PHYSICIAN; PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; THORAX PAIN; VALIDATION STUDY;

AGED; AREA UNDER CURVE; BIOLOGICAL MARKERS; CALCITONIN; CONFIDENCE INTERVALS; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC TESTS, ROUTINE; DISEASE PROGRESSION; DYSPNEA; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PNEUMONIA; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; TIME FACTORS;

EID: 84857539581     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfr177     Document Type: Article

References (15)

1. Mandell LA, Bartlett JG, Dowell SF, File TM Jr, Musher DM, Whitney C. Infectious Disease Society of America. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 2003;37:1405-1433.
2. Menendez R, Ferrando D, Valles JM, Vallterra J. Influence of deviation from guidelines on the outcome of community-acquired pneumonia. Chest 2002;122:612-617.
3. Wuerz RC, Meador SA. Effects of prehospital medications on mortality and length of stay in congestive heart failure. Ann Emerg Med 1992;21:669-674.
4. Mueller C, Scholer A, Laule-Kilian K, Martina B, Schindler C, Buser P, Pfisterer M, Perruchoud AP. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 2004;350:647-654.
5. Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, Mueller B. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 2004;363:600-607.
6. Schuetz P, Christ-Crain M, Wolbers M, Schild U, Thomann R, Falconnier C, Widmer I, Neidert S, Blum CA, Schonenberger R, Henzen C, Bregenzer T, Hoess C, Krause M, Bucher HC, Zimmerli W, Muller B. Effect of procalcitoninbased guidelines compared to standard guidelines on antibiotic use in lower respiratory tract infections: the Randomized-Controlled Multicenter ProHOSP Trial. JAMA 2009;302:1059-1066.
7. Maisel A, Mueller C, Nowak R, Peacock WF, Landsberg JW, Ponikowski P, Möckel M, Hogan C, Wu AH, Richards M, Clopton P, Filippatos GS, Di Somma S, Anand I, Ng L, Daniels LB, Neath SX, Christenson R, Potocki M, McCord J, Terracciano G, Kremastinos D, Hartmann O, von Haehling S, Bergmann A, Morgenthaler NG, Anker SD. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol 2010;55:2062-2076.
8. Fine MJ, Smith DN, Singer DE. Hospitalization decision in patients with community-acquired pneumonia: a prospective cohort study. Am J Med 1990;89:713-721.
9. Leroy O, Santre C, Beuscart C, Georges H, Guery B, Jacquier JM, Beaucaire G. A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit. Intensive Care Med 1995;21:24-31.
10. Harrell FE. Regression Modelling Strategies with Applications to Linear Models, Logistic Regression, and Survival Analysis. New York: Springer; 2001.
11. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008;27:157-172.
12. Meisner M. Procalcitonin-Biochemistry and Clinical Diagnosis. Bremen: UNI-MED Verlag AG; 2010.
13. Mueller B, Harbath S, Stolz D, Bingisser R, Mueller C, Leuppi J, Nusbaumer C, Tamm M, Christ-Crain M. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. BMC Infect Dis 2007;7:10.
14. Iversen KK, Kjaegarrd J, Akkan D, Kober L, Torp-Pedersen K, Hassager C, Vestbo J, Kjoller E, ECHOS Lung Function Study Group. The prognostic importance of lung function in patients admitted with heart failure. Eur J Heart Fail 2010;12:685-691.
15. Gheorghiade M, Follath F, Ponikowski P, Barsuk JH, Blair JEA, Cleland JG, Dickstein K, Drazner MH, Fonarow GC, Jaarsma T, Jondeau G, Sendon JL, Mebazaa A, Metra M, Niemen M, Pang PS, Seferovic P, Stevenson LW, van Velduisen DJ, Zannad F, Anker SD, Rhodes A, McMurray JJ, Filippatos G; European Society of Cardiology; European Society of Intensive Care Medicine. Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail 2010;12:423-433.